Johnson & Johnson hang sales forecasts for  Covid-19 vaccine during the American pharmaceutical giant’s quarterly savings call Tuesday, as insistence lags for that of shots by Moderna and Pfizer. “Given global supply surplus and demand undetermined , the Company is suspends  COVID-19 Vaccine sales knowing,” J&J said in a statement, additionally said that the move will have “no impact to